We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$1.02B
AUM Growth
+$81M
Cap. Flow
+$31.1M
Cap. Flow %
3.05%
Top 10 Hldgs %
45.91%
Holding
127
New
15
Increased
53
Reduced
43
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVRS
126
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
-17,700
Closed -$75K
GCI
127
DELISTED
Gannett Co., Inc
GCI
-10,393
Closed -$111K

Similar funds

Trilogy Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Trilogy Capital held 127 positions worth $1.02B, up 8.6% from $939M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Trilogy Capital deployed $31.1M of net new capital in Q4 2019, opening 15 new positions and adding to 53 existing holdings. Its largest new stake was Hartford Multifactor Developed Markets ex-US ETF: 975,921 shares worth $28.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 0.7% of assets, down from 0.75% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was JPMorgan Diversified Return International Equity ETF, an estimated $28.1M trimmed.

  • Trilogy Capital's largest Q4 2019 buy was Hartford Multifactor Developed Markets ex-US ETF: 975,921 shares worth $28.7M.
  • Trilogy Capital added most to iShares MSCI USA Quality Factor ETF in Q4 2019, an estimated $20.3M increase.
  • Trilogy Capital's biggest Q4 2019 reduction was JPMorgan Diversified Return International Equity ETF, cutting an estimated $28.1M.
  • Trilogy Capital fully exited Invesco S&P 500 High Beta ETF in Q4 2019, selling an estimated $11.3M.
  • Trilogy Capital's ten largest holdings make up 46% of its $1.02B portfolio in Q4 2019.
  • Trilogy Capital opened 15 new positions and closed 12 in Q4 2019.
  • Trilogy Capital's portfolio value rose 8.6% quarter-over-quarter to $1.02B.

Based on Trilogy Capital's 13F filing for Q4 2019, filed 10 Jan 2020.